MediWound (MDWD) EV to CFO (2014 - 2026)
MediWound (MDWD) posted EV to CFO of 16.8 for Q2 2026, up 40.72% on a QoQ basis from 28.34 in Q1 2026, and up 45.25% year-over-year from 11.57 in Q2 2025.
Powered by 
Analysis
MediWound (MDWD) EV to CFO (2014 - 2026) Analysis & Trends
MediWound has reported EV to CFO for 13 years, with the latest figure at 16.8 in Q2 2026.
- On a quarterly basis, EV to CFO rose 45.25% year-over-year to 16.8 in Q2 2026; TTM through Jun 2026 was 6.93, a 40.16% increase from a year earlier, with the FY2025 full-year figure at 11.4, down 4.28% from the prior year.
- EV to CFO was 16.8 for Q2 2026 at MediWound, up from 28.34 in the prior quarter.
- The five-year high for EV to CFO was 44.51 in Q4 2022, with the low at 90.99 in Q4 2024.
- Average EV to CFO over 5 years is 21.9, with a median of 27.5 recorded in 2024.
- The sharpest annual moves came in 2022 and 2024: EV to CFO soared 286.56% in 2022, then plunged 7992.08% in 2024.
- Over 5 years, EV to CFO stood at 44.51 in 2022, then slumped by 144.75% to 19.91 in 2023, then plunged by 356.91% to 90.99 in 2024, then surged by 33.03% to 60.94 in 2025, then surged by 72.43% to 16.8 in 2026.
- The last three EV to CFO figures came in at 16.8 (Q2 2026), 28.34 (Q1 2026), and 60.94 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.80 |
| Mar 31, 2026 | -28.34 |
| Dec 31, 2025 | -60.94 |
| Sep 30, 2025 | -41.80 |
| Jun 30, 2025 | -30.69 |
| Mar 31, 2025 | -40.43 |
| Dec 31, 2024 | -90.99 |
| Sep 30, 2024 | -32.21 |
| Jun 30, 2024 | -31.44 |
| Mar 31, 2024 | -27.50 |
| Dec 31, 2023 | -19.91 |
| Sep 30, 2023 | 8.83 |
| Jun 30, 2023 | -0.39 |
| Mar 31, 2023 | 14.15 |
| Dec 31, 2022 | 44.51 |
| Jun 30, 2022 | -9.04 |
| Mar 31, 2022 | -9.26 |
| Dec 31, 2021 | -23.86 |
| Sep 30, 2021 | -32.22 |
| Jun 30, 2021 | -88.66 |